Magungunan da ake amfani dasu don magance cutar shan-jiji-Ananan kwance
Duk da yake jurewa da cutar kisa , za a kula da ku kuma za a kula da ku saboda kowane rikitarwa. Ɗaya daga cikin gwaji na kowa shi ne cikakken ƙididdigar jini (CBC), wanda ya ba likita bayaninka game da nau'o'in da yawancin kwayoyin jikinsu. Idan jarrabawar CBC ta nuna cewa yawan jinin jininku yana da ƙasa, ƙila za ku kasance anemic .
Jirgin da ke tsakanin Tsakanin Cancer, Chemotherapy, da Anana
Abun cutar zai iya yin yaki da cutar nono kamar yadda ya fi wuya a gare ku; Kuna iya jin rauni sosai, da rashin kunya, da kishi ko kuma gajiya.
Kuna iya ƙin sauƙi ko sauƙi ko kadan. Abun da zai iya raunana jikinka kuma yana cike da tsarin, yana sa ya fi wuyar jikinka don yaki da cutar da kamuwa da cuta.
Idan likitan ka sami anemia sakamakon sakamakon cutar shan-jijiyo, zai iya tsara ku magunguna don taimaka muku samar da ƙarin jinin jini. Aranesp (darbepoetin alfa) da kuma Procrit (epoetin alfa) sune biyu daga cikin magungunan da aka saba amfani dasu don wannan dalili. Aka ba da ta hanyar allura ko ta hanyar jigilar jini (IV), zasu iya bunkasa samar da jinin jininka kuma zai iya taimaka maka ka guje wa buƙatar jini.
Yaya Wadannan Drugs Yi Aiki A Matsayin Boosters na Blood
Ana yin jini a cikin kututtukan ka, nama mai laushi, mai laushi a cikin asalin ka. Kwayoyin da aka yiwa fatalwa sunadaran kwayoyin halitta, wanda kwayar cutar ta shafa. Raƙan ƙwayar kasusuwa na fata yana nufin ƙananan jini. CBC ɗinka na iya bayyana cewa jinin jininka yana da ƙananan, kuma kai ne anemic.
Yawancin lokaci, kodanku suna samar da erythropoietin, wani sinadaran da ke haifar da samar da jinin jinin.
Amma a lokacin chemo don ciwon nono, ƙwayarka na iya ba da isasshen erythropoietin. Gyara da Aranesp su ne maye gurbin mutum ga erythropoietin, kuma yawancin maganin wannan magani zai bunkasa samar da jinin jininku.
Hanyoyin Gaba na Gyara
Gwagwarmayar magani ce mai lafiya, kuma mafi yawan marasa lafiya ba su fuskanci tasiri. Wasu marasa lafiya zasu iya zama zazzaɓi. Kuna da kasa da 22% damar samun wadannan halayen:
- Diarrhea
- Jiɗa
- Vomiting
- Rage riƙe ruwa (edema)
- Wulo
Kiran likitanku idan kuna da wadannan cututtuka:
- Mawuyacin hali (amya, matsalolin numfashi, fatar fuska, lebe, harshe ko maƙara)
- Ƙunƙun zuma
- Rawancin numfashi
- Raƙan daji na numfashi ko rauni (musamman asymmetrical)
- Pain ko kumburi a kafafu, ƙafafun, ko idon kafa
- Hawan jini
- Haske-haske (m, suma)
Hanyoyin Gaba na Aranesp
Aranesp yana da mummunar tasiri, don haka tabbatar da tattauna yiwuwar haɗari da likitan ku. Zai yi aiki tare da ku don ƙayyade ƙimar da za a iya yi don sarrafa yawan ƙwayar jinin ku yayin kula da hadarin gaske. A marasa lafiya da ciwon nono, ƙwayar za ta iya girma da sauri kuma akwai yiwuwar mutuwa nan da nan idan ka dauki Aranesp.
Zai iya haifar da cututtukan zuciya, ciki har da ciwon zuciya, rashin zuciya, da bugun jini. An kuma bayar da rahotanni na jini yayin da yake shan magani tare da Aranesp. Kira ma'aikatan kiwon lafiya naka nan da nan idan kana da wasu daga cikin waɗannan alamun bayyanar:
- Ƙunƙun zuma
- Rashin numfashi ko rashin ƙarfi na numfashi
- Pain ko kumburi a kafafu
- A hannu mai sanyi ko kodadde
- Sauyewar rikice, rikicewa magana ko wahalar fahimtar wasu
- Dama a fuskarka, makamai, kafafu ko kuma gefe ɗaya na jikinka
- Tana ganin matsala
- Matsarar da ke cikin tafiya
- Rashin sani
Aranesp yana da wasu cututtuka masu tsanani, ciki har da cutar hawan jini, sacewa, kwayoyin cutar zuwa Aranesp, ma'ana jikinka zai iya toshe Aranesp kuma ya kara da cutar anemia da kuma mummunar halayen rashin lafiyar.
Bayanai yayin Jiyya
Kafin karon farko na Aranesp ko Procrit, likita zai umurci CBC don samun matakan jinin jininka, haemoglobin , hematocrit , da baƙin ƙarfe.
Yayin da jiyya ke ci gaba, za ku sami ƙarin gwaje-gwajen jini don bincika tasiri na miyagun ƙwayoyi kuma don tabbatar da cewa kana samun kashi mai kyau.
Kafin fara wani magani, yi magana da likitanka game da buƙatarka da hadarin da ke tattare da kullun.
Sources:
Abinci da Drug Administration. "Aranesp Bayani Bayani." Revised 2015.
Abinci da Drug Administration. "Bayyana Bayanan Bayanai," Revised 2013.
"Araspen Labeling Revision." FDA Bayyana Bayanan Tsaro na Drug don Magunguna da Doctors, 2013.
Muller, R., Baribeault, D. "Tsarin tsoma-tsintsin lokaci-lokaci na ma'aikatan erythropoietic in chemotherapy-induced anemia". American Journal of Health-System Pharmacy , 2007, 2547-2556.